Population‐based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA‐DQB1, HLA‐DQA1 and HLA‐DRB1 loci

Aims To improve sensitivity and specificity of the diabetes risk assessment of the population‐based genetic screening used in the Finnish Diabetes Prediction and Prevention (DIPP) trial.

[1]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[2]  S G Marsh,et al.  HLA class II region sequences, 1998. , 2008, Tissue antigens.

[3]  M. Baur,et al.  Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. , 1988, American journal of human genetics.

[4]  J. Todd.  Genetic analysis of type 1 diabetes using whole genome approaches. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Ilonen,et al.  Triple-label hybridization assay for type-1 diabetes-related HLA alleles. , 1995, BioTechniques.

[6]  M. Knip,et al.  IDDM prevention trials in progress--a critical assessment. , 1998, Journal of pediatric endocrinology & metabolism : JPEM.

[7]  Z. Layrisse,et al.  HLA‐DQA1 AND DQB 1 ALLELE AND GENOTYPE CONTRIBUTION TO IDDM SUSCEPTIBILITY IN AN ETHNICALLY MIXED POPULATION , 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[8]  A. Barnett,et al.  HLA-DQA1 and -DQB1 Alleles Associated With Genetic Susceptibility to IDDM in a Black Population , 1991, Diabetes.

[9]  E. Gale,et al.  Theory and Practice of Nicotinamide Trials in Pre-Type 1 Diabetes , 1996, Journal of pediatric endocrinology & metabolism : JPEM.

[10]  B. Parfait,et al.  HLA-DQβl Typing and Non-Asp57 Alleles in the Aborigine Population of Senegal , 1995, Diabetes Care.

[11]  J. Ilonen,et al.  Costs of predicting IDDM , 1998, Diabetologia.

[12]  Å. Lernmark,et al.  POPULATION ANALYSIS OF PROTECTION BY HLA‐DR AND DQ GENES FROM INSULIN‐DEPENDENT DIABETES MELLITUS IN SWEDISH CHILDREN WITH INSULIN‐DEPENDENT DIABETES AND CONTROLS , 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[13]  D. Wagener,et al.  The Pittsburgh Study of Insulin-Dependent Diabetes Mellitus: Risk for Diabetes Among Relatives of IDDM , 1982, Diabetes.

[14]  J. Ilonen,et al.  The Effect of HLA-B Allele on the IDDM Risk Defined by DRB1*04 Subtypes and DQB1*0302 , 1997, Diabetes.

[15]  J. Ilonen,et al.  Time-Resolved Fluorometry Based Sandwich Hybridisation Assay for HLA-DQA1 Typing , 2002, Disease markers.

[16]  E. Thorsby,et al.  Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. , 1991, Tissue antigens.

[17]  J. She.  Susceptibility to type I diabetes: HLA-DQ and DR revisited. , 1996, Immunology today.

[18]  J. Ilonen,et al.  HLA-DR4 subtype and -B alleles in DQB1*0302-positive haplotypes associated with IDDM. The Childhood Diabetes in Finland Study Group. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[19]  R. Slover,et al.  Prevention of type I diabetes and recurrent beta-cell destruction of transplanted islets. , 1997, Endocrine reviews.

[20]  F. Muntoni,et al.  Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. , 1993, Human immunology.

[21]  P. H. Moghaddam,et al.  Genetic Structure of IDDM1: Two Separate Regions in the Major Histocompatibility Complex Contribute to Susceptibility or Protection , 1998, Diabetes.

[22]  J. Ilonen,et al.  Distribution of insulin-dependent diabetes mellitus (IDDM)-related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region. , 1998, Tissue antigens.

[23]  F. Schuit,et al.  Genetic structure of IDDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry. , 1998, Diabetes.

[24]  Amanda J. Wilson,et al.  A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients , 1998, Nature Genetics.

[25]  J. Ilonen,et al.  Rapid HLA-DQB1 Genotyping for Four Alleles in the Assessment of Risk for IDDM in the Finnish Population , 1996, Diabetes Care.